Business
Nigeria’s Broken Systems: Why Failure Persists and What Must Change
An analysis of the structural and institutional factors that entrench governance failures in Nigeria, from patronage politics and weakened oversight to the urgent need…
Biden’s doctor reportedly met with top neurologist at White House
The revelation that Dr Kevin Cannard, a Parkinson's disease specialist from Walter Reed National Military Medical Center, met with President Biden's long-time physician Dr Kevin O'Connor at the White House residence clinic in January has added fuel to an already heated discussion about the president's mental acuity. The meeting, uncovered through visitor logs reviewed by the New York Post, comes amid growing pressure on Biden to address concerns about his fitness for office, particularly after a widely criticised debate performance against Donald Trump. Despite consistent reassurances from the White House and Biden himself that he undergoes daily cognitive assessment through his duties, the frequency of Cannard's visits — eight since August 2023 — has raised questions among critics and medical observers alike.
The White House Visit and Its Context
Dr Kevin Cannard, a Parkinson's disease specialist from Walter Reed National Military Medical Center, met with President Biden's long-time physician Dr Kevin O'Connor at the White House residence clinic on January 17. The meeting, uncovered through visitor logs reviewed by the New York Post, is one of eight Cannard visits since August 2023. Cannard has served as a neurology specialist supporting the White House medical unit since 2012 and published a 2023 paper on early-stage brain degeneration in Parkinsonism & Related Disorders. Of the eight visits, seven involved Megan Nasworthy, a Walter Reed–White House liaison, suggesting primarily administrative or consultative interaction. Only the January 17 encounter was recorded as a direct meeting with Dr O'Connor. The White House has not disclosed the nature of the discussion.
Biden's Stance on Cognitive Testing
President Biden has repeatedly declined independent cognitive assessment, most recently during his ABC News interview with George Stephanopoulos after the presidential debate. When asked about specific cognitive tests, Biden responded: "No one said I had to … they said I'm good." He later claimed, "I get a cognitive test every day. Everything I do — you know, not only am I campaigning, but I'm running the world." This echoes his 2020 dismissal: "Why the hell would I take a test?" Biden's three annual physicals during his presidency have not included cognitive screening, and Dr O'Connor has never recommended such evaluation. The White House defends this approach; Press Secretary Karine Jean-Pierre previously justified O'Connor's decision not to administer a cognitive test, particularly after special counsel Robert Hur's report described Biden as a "well-meaning elderly man with a poor memory." Biden responded: "I'm well-meaning, and I'm elderly, and I know what I'm doing. My memory is fine."
Political Reactions and Public Skepticism
The neurologist visit has drawn sharp criticism from former White House physician Ronny Jackson, now a Republican congressman from Texas. Jackson has long urged Biden to undergo a cognitive exam and accused Dr O'Connor and the Biden family of concealing potential health issues. To the New York Post, Jackson said: "Kevin O'Connor is like a son to Jill Biden — she loves him," adding "they knew they could trust Kevin to say and do anything that needed to be said or done." Radio hosts Earl Ingram and Andrea Lawful-Sanders, who interviewed Biden before the ABC appearance, claimed they received pre-approved question lists from the campaign with no negotiation. Ingram told the Associated Press: "They gave me the exact questions to ask. There was no back and forth." Lawful-Sanders received eight questions and selected four. Campaign spokesperson Lauren Hitt defended the practice as standard, noting acceptance was not a prerequisite. Both interviews were structured to highlight Biden's outreach to Black voters.
Implications for Leadership and Global Perception
The ongoing discussion about Biden's cognitive health carries implications for international confidence in U.S. leadership. In an era of geopolitical tension, economic uncertainty, and rapid technological change, perceptions of stability in the world's largest economy influence investment decisions, diplomatic engagement, and market behaviour. While no official diagnosis has been released, repeated avoidance of transparent health disclosures fuels speculation. In global markets, where predictability and clear communication are valued, prolonged ambiguity around a leader's fitness can contribute to risk aversion among foreign investors and multinational corporations assessing exposure to U.S. policy shifts. The situation raises broader questions about norms governing medical transparency in public office. Unlike some nations requiring regular health disclosures for heads of state, the U.S. relies largely on voluntary disclosure and periodic physical summaries. As democracies confront ageing leadership cohorts, the Biden case may prompt renewed debate about balancing privacy with the public's right to know.
Medical Ethics and the Role of Physicians in High-Office Care
The dynamic between Dr O'Connor and Dr Cannard highlights ethical complexities faced by physicians treating senior public figures. Dr Cannard's specialist background in neurodegenerative conditions means his involvement, even consultatively, invites scrutiny. Without confirmed symptoms or diagnosis, any inference remains speculative. Medical ethics guidelines emphasise patient confidentiality and avoiding premature conclusions. Physicians in high-profile roles must navigate dual obligations: providing competent care while respecting privacy, within an environment where actions may be interpreted politically. Dr O'Connor's description of his role — offering Biden an affirmative "Good morning, Mr President" to start the day — reflects a supportive, relationship-based model. While continuity can be beneficial, it raises questions about whether long-term physician-patient relationships might inhibit objective assessment, particularly when cognitive changes are subtle or gradual.
What this means
The reported meeting between President Biden's physician and a White House neurologist underscores the intense scrutiny accompanying public leadership. Although no evidence of cognitive impairment has been formally presented, the combination of specialist visits, repeated refusals of independent testing, and high-profile missteps creates a context where perception often shapes reality as much as fact. For businesses, investors, and global observers, the episode highlights the importance of clear, credible communication from institutions — especially when leadership stability is perceived as uncertain. In an interconnected world where political developments ripple through markets and supply chains, transparency is not merely accountability; it is risk management. As democratic nations confront ageing leadership, the Biden case may contribute to evolving expectations about how health, duty, and public trust intersect in high office.
Originally reported by theguardian.com. Adapted for our readers with AI assistance.
